Eric Beausoleil

648 total citations
10 papers, 552 citations indexed

About

Eric Beausoleil is a scholar working on Molecular Biology, Organic Chemistry and Pharmacology. According to data from OpenAlex, Eric Beausoleil has authored 10 papers receiving a total of 552 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Molecular Biology, 3 papers in Organic Chemistry and 2 papers in Pharmacology. Recurrent topics in Eric Beausoleil's work include Chemical Synthesis and Analysis (6 papers), Biochemical and Molecular Research (2 papers) and Berberine and alkaloids research (1 paper). Eric Beausoleil is often cited by papers focused on Chemical Synthesis and Analysis (6 papers), Biochemical and Molecular Research (2 papers) and Berberine and alkaloids research (1 paper). Eric Beausoleil collaborates with scholars based in Canada, United States and France. Eric Beausoleil's co-authors include William D. Lubell, Ronald N. Zuckermann, Fred E. Cohen, Surinder Kaur, Timothy S. Burkoth, Stephen W. Michnick, Catherine De Oliveira, Fabien Schweighoffer, S. Lacombe and Laurent Bélec and has published in prestigious journals such as Journal of the American Chemical Society, Journal of Biological Chemistry and The Journal of Organic Chemistry.

In The Last Decade

Eric Beausoleil

10 papers receiving 531 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Eric Beausoleil Canada 9 440 242 51 42 35 10 552
Rebecca F. Wissner United States 14 475 1.1× 244 1.0× 55 1.1× 48 1.1× 30 0.9× 15 691
Nilsa Graciani United States 11 272 0.6× 156 0.6× 36 0.7× 55 1.3× 43 1.2× 14 547
Chongwu Zhang United States 8 310 0.7× 205 0.8× 26 0.5× 37 0.9× 64 1.8× 9 424
René Hersperger Switzerland 14 470 1.1× 194 0.8× 32 0.6× 58 1.4× 14 0.4× 19 687
Paul M. Levine United States 17 637 1.4× 363 1.5× 45 0.9× 105 2.5× 58 1.7× 24 860
Marie-Noëlle Dufour France 11 406 0.9× 247 1.0× 21 0.4× 27 0.6× 63 1.8× 16 586
John J. Ferrie United States 17 469 1.1× 143 0.6× 30 0.6× 96 2.3× 54 1.5× 26 699
M. Muralidhar Reddy United States 17 805 1.8× 520 2.1× 80 1.6× 61 1.5× 13 0.4× 32 1.1k
Anupam Patgiri United States 9 708 1.6× 246 1.0× 22 0.4× 32 0.8× 14 0.4× 11 831
Soan Cheng United States 9 326 0.7× 213 0.9× 33 0.6× 53 1.3× 30 0.9× 10 544

Countries citing papers authored by Eric Beausoleil

Since Specialization
Citations

This map shows the geographic impact of Eric Beausoleil's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eric Beausoleil with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eric Beausoleil more than expected).

Fields of papers citing papers by Eric Beausoleil

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Eric Beausoleil. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eric Beausoleil. The network helps show where Eric Beausoleil may publish in the future.

Co-authorship network of co-authors of Eric Beausoleil

This figure shows the co-authorship network connecting the top 25 collaborators of Eric Beausoleil. A scholar is included among the top collaborators of Eric Beausoleil based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Eric Beausoleil. Eric Beausoleil is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

10 of 10 papers shown
1.
Bachelot, Florence, Catherine De Oliveira, Thierry Taverne, et al.. (2012). Vascular disrupting activity and the mechanism of action of EHT 6706, a novel anticancer tubulin polymerization inhibitor. Investigational New Drugs. 31(2). 304–319. 3 indexed citations
2.
Kotraiah, Vinayaka, et al.. (2012). Identification of aldehyde dehydrogenase 1A1 modulators using virtual screening. Journal of Enzyme Inhibition and Medicinal Chemistry. 28(3). 489–494. 16 indexed citations
3.
Beausoleil, Eric, Thierry Taverne, S. Lacombe, et al.. (2009). Structure–activity relationship of isoform selective inhibitors of Rac1/1b GTPase nucleotide binding. Bioorganic & Medicinal Chemistry Letters. 19(19). 5594–5598. 14 indexed citations
4.
Désiré, Laurent, Virginie Picard, Catherine De Oliveira, et al.. (2005). RAC1 Inhibition Targets Amyloid Precursor Protein Processing by γ-Secretase and Decreases Aβ Production in Vitro and in Vivo. Journal of Biological Chemistry. 280(45). 37516–37525. 117 indexed citations
5.
Burkoth, Timothy S., et al.. (2002). Toward the Synthesis of Artificial Proteins. Chemistry & Biology. 9(5). 647–654. 95 indexed citations
7.
Uno, Tetsuo, Eric Beausoleil, Richard Goldsmith, Barry H. Levine, & Ronald N. Zuckermann. (1999). New submonomers for poly N-substituted glycines (peptoids). Tetrahedron Letters. 40(8). 1475–1478. 42 indexed citations
8.
Beausoleil, Eric, et al.. (1998). Alkyl 3-Position Substituents Retard the Isomerization of Prolyl and Hydroxyprolyl Amides in Water. The Journal of Organic Chemistry. 63(19). 6572–6578. 49 indexed citations
9.
Beausoleil, Eric & William D. Lubell. (1996). Steric Effects on the Amide Isomer Equilibrium of Prolyl Peptides. Synthesis and Conformational Analysis of N-Acetyl-5-tert-butylproline N‘-Methylamides. Journal of the American Chemical Society. 118(51). 12902–12908. 139 indexed citations
10.
Beausoleil, Eric, et al.. (1996). 5-tert-Butylproline. The Journal of Organic Chemistry. 61(26). 9447–9454. 50 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026